Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Altos Labs

Biotech & Life Sciences · Los Altos, United States · Founded 2021 Decacorn

Biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation programming

Valuation
$10–50B
Latest valuation · 2026
Unlock exact value
Headcount
500–1k
Current team size
Unlock exact value

Investors

4 investors on Altos Labs's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

Global footprint

Where Altos Labs has talent and traffic

AI talent share
4.2% of workforce is AI talent
(24 of 566 staff)
Core AI203.53%
Other AI40.71%
Non-AI workforce54295.76%
Workforce by country
11 countries with
team presence
🇺🇸 United States72.8%
🇬🇧 United Kingdom24.3%
🇪🇸 Spain0.8%
🇵🇹 Portugal0.7%
🇨🇦 Canada0.3%
Top 5 of 11 shown
Web traffic by country
54K monthly visits
across markets
🇨🇦 Canada24.1%
🇺🇸 United States22.4%
🇩🇪 Germany8.3%
🏳️ Korea8.3%
🏳️ Republic of6.9%
Top 5 markets shown

Patent intelligence

$6M patent portfolio · 10 active families

Estimated portfolio value
$6M
0.03% of valuation · 41.6× smaller than top peer Juno Therapeutics ($239M)
10 active patent families
Where Altos Labs innovates Cell biologyBiochemistryBiophysicsMolecular biologyIntegrated stress response

Where Altos Labs concentrates vs peers

Each axis is a top-10 topic across Altos Labs and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Altos Labs's 1 investments and acquisitions.

Every disclosed deal where Altos Labs appeared as a backer or acquirer, 2025–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

1 deals across Altos Labs's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Altos Labs's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        1 of 1 deals

        Market sentiment

        What the market is saying about Altos Labs

        An AI-synthesized read of the highest-engagement posts about Altos Labs on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Altos Labs on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.